JUL 30, 2019 11:39 AM PDT

Treating Drug-Resistant Acute Lymphoblastic Leukemia

WRITTEN BY: Nouran Amin

New therapeutics may have helped improve survival rates for acute lymphoblastic leukemia patients but some patients still remain unresponsive to existing treatment regimens. To make matters worse, drug resistance is not the only concern--the risk of drug-related toxicities among patients has pushed researchers to seek safer and effective therapeutics.

Now, scientists from Case Western Reserve University School of Medicine have developed a novel combination treatment regimen that enhances immune system function and improve the ability to kill leukemia’s that do not respond to standard protocol treatments. Findings were published in Cancer Immunology Research and describes the use of mouse models to illustrate how an antibody attaches to a specific protein on the cell surface of acute lymphoblastic leukemia cells and creates a bridge by attaching to a natural killer that quickly works to eradicate the cancer cell.

"If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatment was administered late when the tumor had grown and established its own microenvironment, the antibody alone was less effective," said Parameswaran, who is also a member of the Case Comprehensive Cancer Center and a St. Baldrick's Scholar. "There was a clear negative effect of the tumor microenvironment on natural killer cell killing capacity," Parameswaran said. "So, we added a TGF-beta receptor inhibitor to our antibody treatment regimen."

Watch this video below to learn more on acute lymphoblastic leukemia:

The treatment uses BAFF-R antibody, which attaches to the BAFF-R protein on cancer cells. The antibody is currently being used to treat autoimmune diseases and rheumatoid arthritis in two clinical trial studies.

"We looked at BAFF-R expression in a small group of 16 patients and all of them expressed this receptor. It's promising as a therapeutic avenue for late-stage disease" Parameswaran said. Data from larger patient sets will help us draw a definitive conclusion."

Source: Case Western University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 10, 2020
Drug Discovery & Development
FDA Approves New Antibiotic for Hospital-Acquired Pneumonia
JUN 10, 2020
FDA Approves New Antibiotic for Hospital-Acquired Pneumonia
The US Food and Drug Administration (FDA) has approved Recarbrio, an antibiotic drug created by pharmaceutical company M ...
JUN 16, 2020
Microbiology
A Bacterial Compound Could Become a Treatment for Parasitic Infections
JUN 16, 2020
A Bacterial Compound Could Become a Treatment for Parasitic Infections
The World Health Organization has estimated that parasitic infections cause over 48 million cases of illness and 59,000 ...
JUN 15, 2020
Drug Discovery & Development
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
JUN 15, 2020
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
Researchers from Princeton University have identified a compound capable of killing both Gram-positive and Gram-negative ...
JUN 07, 2020
Drug Discovery & Development
Repurposing An Antibiotic To Defeat a Deadly Superbug
JUN 07, 2020
Repurposing An Antibiotic To Defeat a Deadly Superbug
A recent study published in Nature Microbiology describes how an old antibiotic used for Tuberculosis can be powerful tr ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
JUL 29, 2020
Cancer
Regulating Apoptosis in Prostate Cancer
JUL 29, 2020
Regulating Apoptosis in Prostate Cancer
Cancer treatments tend to work in one of a few ways. They can target the immune system, prevent cancer proliferation and ...
Loading Comments...